相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood
Zhong Wang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma
Linlin Yan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma
Zhi-Xiong Cai et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma
Henrike Julich-Haertel et al.
JOURNAL OF HEPATOLOGY (2017)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma A meta-analysis
Chi Sun et al.
MEDICINE (2017)
Detection of circulating tumor cells by reverse transcription-quantitative polymerase chain reaction and magnetic activated cell sorting in the peripheral blood of patients with hepatocellular carcinoma
Limin Guo et al.
MOLECULAR MEDICINE REPORTS (2017)
Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions
Lisanne F. van Dessel et al.
MOLECULAR ONCOLOGY (2017)
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
Rui-hua Xu et al.
NATURE MATERIALS (2017)
An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
Mark Kalinich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection
Johann von Felden et al.
ONCOTARGET (2017)
Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring
Yi Chang et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients
Jing Chen et al.
CANCER BIOMARKERS (2017)
XRCC1 rs25487 genetic variant and TP53 mutation at codon 249 predict clinical outcomes of hepatitis B virus-related hepatocellular carcinoma after hepatectomy: A cohort study for 10 years' follow up
Long Yu et al.
HEPATOLOGY RESEARCH (2016)
Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection
Yan Zhou et al.
BMC CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay
Yu Zhang et al.
CANCER BIOLOGY & THERAPY (2016)
AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis
Junhua Jin et al.
CANCER LETTERS (2016)
Imagestream detection and characterisation of circulating tumour cells - A liquid biopsy for hepatocellular carcinoma?
Laura F. Ogle et al.
JOURNAL OF HEPATOLOGY (2016)
Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies
Stanislav Volik et al.
MOLECULAR CANCER RESEARCH (2016)
Circulating tumour cells as biomarkers for evaluating cryosurgery on unresectable hepatocellular carcinoma
Jian Shi et al.
ONCOLOGY REPORTS (2016)
Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepotocellular Circulating Tumor Cells Enrichment
Shuyi Wang et al.
THERANOSTICS (2016)
Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
Ao Huang et al.
JOURNAL OF CANCER (2016)
Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
Ao Huang et al.
JOURNAL OF CANCER (2016)
Circulating tumor cell detection in hepatocellular carcinoma based on karyoplasmic ratios using imaging flow cytometry
Zixin Liu et al.
SCIENTIFIC REPORTS (2016)
The incidence and mortality of major cancers in China, 2012
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER (2016)
Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma
Gi Hong Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls
Robin K. Kelley et al.
BMC CANCER (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
Peiyong Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Improved method increases sensitivity for circulating hepatocellular carcinoma cells
Hui-Ying Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells
Peter Ping Lin
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Circulating biomarkers in hepatocellular carcinoma
Karen L. Morris et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Clinical Significance of EpCAM mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR-Based Platform
Wei Guo et al.
CLINICAL CANCER RESEARCH (2014)
Evaluation of INK4A promoter methylation using pyrosequencing and circulating cell-free DNA from patients with hepatocellular carcinoma
Gengming Huang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Aberrant DNA Methylation of G-protein-coupled Bile Acid Receptor Gpbar1 (TGR5) is a Potential Biomarker for Hepatitis B Virus Associated Hepatocellular Carcinoma
Li-Yan Han et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2014)
WRITTEN IN BLOOD DNA circulating in the bloodstream could guide cancer treatment - if researchers can work out how best to use it
Ed Yong
NATURE (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
Jun Li et al.
PLOS ONE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Identification of biomarkers for hepatocellular carcinoma by semiquantitative immunocytochemistry
Hong Mu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease
Abeer A. Bahnassy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma
Xiang-Fen Ji et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Real-time Liquid Biopsy in Cancer Patients: Fact or Fiction?
Klaus Pantel et al.
CANCER RESEARCH (2013)
Detection of TFPI2 Methylation in the Serum of Hepatocellular Carcinoma Patients
Feng-Kai Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Expression of Intercellular Adhesion Molecule 1 by Hepatocellular Carcinoma Stem Cells and Circulating Tumor Cells
Shupeng Liu et al.
GASTROENTEROLOGY (2013)
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma
Min Yao et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2013)
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
Yun-Fan Sun et al.
HEPATOLOGY (2013)
Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip
Pengjun Zhang et al.
HEPATOLOGY INTERNATIONAL (2013)
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma
Marika Piciocchi et al.
HEPATOLOGY INTERNATIONAL (2013)
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma
Kornelius Schulze et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients
Audrey Vallee et al.
LUNG CANCER (2013)
Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease
Y-M Li et al.
CELL DEATH & DISEASE (2013)
Isolation and retrieval of circulating tumor cells using centrifugal forces
Han Wei Hou et al.
SCIENTIFIC REPORTS (2013)
Intratumor Heterogeneity: Evolution through Space and Time
Charles Swanton
CANCER RESEARCH (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Quantitation of Plasma Circulating DNA Using Quantitative PCR for the Detection of Hepatocellular Carcinoma
Zhaohui Huang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
Nadia A. Mohamed et al.
Arab Journal of Gastroenterology (2012)
Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers
Norio Iizuka et al.
CLINICA CHIMICA ACTA (2011)
Isolation of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Using a Novel Cell Separation Strategy
Wen Xu et al.
CLINICAL CANCER RESEARCH (2011)
Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma
Zhao-Hui Huang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Serum and Urine Metabolite Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma
Tianlu Chen et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients
Priyanka Iyer et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Non-viral causes of hepatocellular carcinoma
Wojciech Blonski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients withMetastaticBreast Colorectal and Prostate Cancer
M. Craig Miller et al.
JOURNAL OF ONCOLOGY (2010)
MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
Mitch Raponi et al.
CANCER RESEARCH (2009)
Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma
Sun-Young Kong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2008)
Methylation of tumor associated genes in tissue and plasma samples from liver disease patients
Hong Chang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Diagnosis and treatment of hepatocellular carcinoma
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA
Yu-Jing Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer:: A validation study of the CellSearch system
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2007)
The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma
N Ren et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma
W Yeo et al.
LIVER INTERNATIONAL (2005)
Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer
G Vona et al.
HEPATOLOGY (2004)
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma
U Cillo et al.
CLINICA CHIMICA ACTA (2004)
Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
KS Jeng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Frequent EpCam protein expression in human carcinomas
PT Went et al.
HUMAN PATHOLOGY (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
Changes in concentration of DNA in serum and plasma during storage of blood samples
M Jung et al.
CLINICAL CHEMISTRY (2003)
Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells
DC Mou et al.
BRITISH JOURNAL OF CANCER (2002)
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma
H Witzigmann et al.
SURGERY (2002)
Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation
IHN Wong et al.
CANCER LETTERS (2001)
Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma
TH Lee et al.
TRANSFUSION (2001)
Isolation by size of epithelial tumor cells - A new method for the immunomorphological and molecular characterization of circulating tumor cells
G Vona et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
